Cleared Traditional

K260374 - Empatica Health Monitoring Platform for Parkinson's Disease Monitoring

Also marketed or referenced as:
EmbracePlus EmbraceMini Empatica Care PKG Monitor by Empatica Care Portal

K260374 is an FDA 510(k) clearance for Empatica Health Monitoring Platform for..., manufactured by Empatica S.R.L.. The device is a Class 2 Neurology device with product code GYD cleared through the Traditional 510(k) pathway after a 190-day FDA review.

K260374 · Empatica S.R.L. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2026
Decision
190d
Days
Class 2
Risk

K260374 is an FDA 510(k) clearance for the Empatica Health Monitoring Platform for Parkinson's Disease Monitoring. Classified as Transducer, Tremor (product code GYD), Class II - Special Controls.

Submitted by Empatica S.R.L. (Milan, IT). The FDA issued a Cleared decision on August 14, 2026 after a review of 190 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1950 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Empatica S.R.L. devices

FDA 510(k) Submission Details - K260374

510(k) Number K260374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2026
Decision Date August 14, 2026
Days to Decision 190 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 148d · This submission: 190d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GYD Device Classification - Class 2, Special Controls

Product Code GYD Transducer, Tremor
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GYD Transducer, Tremor

All 11
Devices cleared under the same product code (GYD) and FDA review panel - the closest regulatory comparables to K260374.
Kneu Platform (V2)
K262515 · Kneu Health Digital , Ltd. · Aug 2026
Sine Monitoring Parkinson’s Disease Tremor Dyskinesia Apple Watch (“SMPDTDAW”)
K253055 · Nordic Kinetics AB · Jun 2026
Neu Platform
K250153 · Neuhealth Digital , Ltd. · Apr 2025
NeuroRPM
K221772 · New Touch Digital, Inc. · Mar 2023
Parky App
K220820 · H2o Bilisim Yazilim · Nov 2022
Rune Labs Tremor Transducer System
K213519 · Rune Labs, Inc. · Jun 2022